Omthera Pharmaceuticals, Inc. — Form D
Omthera Pharmaceuticals, Inc. of NEW JERSEY, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2009-11-27. $2.2M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2009-11-27
- Form: D
- Accession: 0001477598-09-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Amount sold: $2.2M
- Investors: 4
- Date of first sale: 2009-11-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-136458
Issuer
- Name: Omthera Pharmaceuticals, Inc.
- CIK: 0001477598
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 707 STATE ROAD, NEW JERSEY, NJ, 08540
- Phone: 908-741-4399
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Michael Davidson | Executive Officer | South San Francisco, CA |
| Graziano Seghezzi | Director | Paris, I0 |
| Douglas Carr | Executive Officer | Philadelphia, PA |
| Christian Schade | Executive Officer | Harrison, NY |
| BERNARDUS MACHIELSE | Executive Officer | CAMBRIDGE, MA |
| David Mott | Director | Chevy Chase, MD |
| Gerald Wisler | Director | Waban, MA |
| Gerald Wisler | Executive Officer | Waban, MA |
| George Horner | Director | Princeton, NJ |
Other filings by this issuer (3)
More